China NMPA Launches Online Platform for Non-Clinical Drug Safety Evaluation Institutions 
October 16, 2025 

The National Medical Products Administration (NMPA) has introduced an online registration platform via its Government Service Portal (ZWFW) for non-clinical drug safety evaluation research institutions (GLP labs). 

This initiative aims to digitize and streamline oversight of institutions performing pre-clinical safety studies, ensuring compliance and transparency in supporting drug development and registration. 

Key Highlights: 

  • Digital Platform Launch: Labs can register, update, and verify information online.
  • Scope: Applicable to profit-making legal entities conducting non-clinical safety research.
  • Application Process: Fee-free, fully online, with immediate confirmation upon submission.
  • Support & Consultation: Dedicated hotlines for business and technical guidance. 

Purpose: 
Enhances regulatory transparency, data traceability, and compliance oversight for laboratories performing non-clinical safety evaluations critical for pre-clinical drug research. 

Consult Now

Source
https://zwfw.nmpa.gov.cn/web/index
Select Mandate HA
NMPA
Select Mandate Function
Country Regulatory Affairs